June 15th is the cutoff for “enrolling” patients in both trials. Then they need to treat the latest enrolled patients (June 15th) with Leronlimab for ~2 weeks. Takes us to the end of June. Then they need to unblind the results and start to process the findings, lots of patient details being captured, as part of the protocol in addition to finishing any remaining Dr. BP’s blood diagnostics. Finally tabulate results, do statistical analysis, etc... this will take us to mid July? Finally prepare findings in presentations and get engaged with FDA, answer questions, etc... Then they are in the hands of the FDA around end of July!!